Nanovesicles from Fruit Extracts for Breast Cancer Therapy
Paper ID : 1155-IGA
Authors
Afrooz Sepahvand *
Department of Cellular and Molecular Biology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
Abstract
Nanobiotechnology has revolutionized cancer treatment, offering
new strategies for targeted drug delivery. Nanovesicles, in particular those synthesized
using biological sources such as fruit extracts, can be applied for cancer treatment, This
tudy aims to review the application of nanovesicles synthesized from fruit extracts in
breast cancer treatment.
Methods: The published papers were reviewed using well-known sources such as Google
Scholar, PubMed, Clarivate, ScienceDirect, and Scopus. The key terms including
nanovesicles," "fruit extract," "cancer," "breast cancer," and "treatment" were used to find
the best related papers. Peer-reviewed articles and clinical studies published in the last
decade were reviewed and analyzed
Results: Recently research has focused on the potential of fruit extract-derived
nanovesicles (FDNVs) application in breast cancer treatment. Early studies revealed the
significant antioxidant properties of FDNVs. As research progressed, scientists found
that FDNVs can be applied in targeted drug delivery systems; for instance, ginger-derived
anoparticles could enhance the delivery capabilities in cancer models. Isolating and
characterizing FDNVs from fruits like blueberries and citrus, has been reported recently to
increase the ability of nanovesicles to induce the cancer signaling pathways in vitroin
cancer cells including breast cancer cells.
Conclusion: Although there are significant challenges in application of FDNVs for breast
treatment, the research underscores the potential of FDNVs as therapeutic agents
cancer
in cancer treatment as well as using FDNVs as vehicles for chemotherapeutic drugs.
urther in vitro and in vivo research are required to reveal the exact role played by FDNVs
in breast cancer therapy.
Keywords
Fruit extract-derived nanovesicles, Drug delivery systems, Breast cancer therapy, Targeted treatment, Nano-based therapeutics
Status: Accepted